Patent details

EP1724284 Title: GLP-1 fusion proteins

Basic Information

Publication number:
EP1724284
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP061189759
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLP-1 fusion proteins
French Title of Invention:
Protéine de fusion de GLP-1
German Title of Invention:
GLP-1 Fusionsproteine
SPC Number:

Dates

Filing date:
29/11/2001
Grant date:
29/07/2009
EP Publication Date:
29/07/2009
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/11/2006
EP B1 Publication Date:
29/07/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/11/2001
 
 

Name:
Eli Lilly & Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/07/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Tschang Sheng-Hung Rainbow
Address:
United States (US)

2

Name:
Micanovic Radmila
Address:
United States (US)

3

Name:
Glaesner Wolfgang
Address:
United States (US)

Priority

Priority Number:
251954 P
Priority Date:
07/12/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/605;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
15/10/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages